Efficacy of Neelkanthi churna in Madhumeha w.s.r to Type 2 Diabetes Mellitus

Not Applicable

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2021/06/034030
• Lead Sponsor: Principal

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1) Patients of either sex aged between 20-70yrs.

2) Newly diagnosed patients of Type 2 Diabetes Mellitus having glycosylated Hb (HbA1C) between 6.5% to 10%

3) Patients willing to participate in the trial.

Exclusion Criteria

Subject of Type-1 DM or Type-2 DM on insulin/OHAââ?¬•s other than Metformin/ any other medication for glucose control in the last 3 months

Subjects suffering from the complications of Diabetes Mellitus viz., diabetic neuropathy, diabetic nephropathy, diabetic retinopathy etc. which require an urgent treatment.

Patients having major medical illness like cancer, concurrent infection like tuberculosis.

Patients with uncontrolled Hypertension.

Patients with established diagnosis of CAD or any other clinically significant cardiovascular disease.

Renal dysfunction (defined by eGFR < 60ml/min calculated by MDRD calculator)

Subjects who have completed participation in any other clinical trial during the past 3 months.

Any other condition which the investigator thinks may compromise the safety of subject.

Subjects with Haemoglobin percentage < 9gm% for males and < 8gm%for females.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fulfillment of objective and subjective criteriaTimepoint: 12 weeks

Secondary Outcome Measures

Name	Time	Method
Efficacy of Neelkanthi Churna in type 2 Diabetes MellitusTimepoint: 12 weeks